howard hochster, md, on whether atezolizumab bevacizumab regimen is a new standard in care in hcc
Published 4 years ago • 379 plays • Length 4:23
Download video MP4
Download video MP3
Similar videos
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
2:40
key outcomes of the phase 1b of atezolizumab and bevacizumab for advanced hcc
-
1:56
howard hochster, md on mcrc treatment changes due to primary site of tumor impact.
-
1:12
ahmed kaseb, md, elaborates on the phase 1b study investigating atezolizumab bevacizumab in hcc
-
1:39
howard s. hochster, md, on integrating immunotherapy into treatment regimens for gi cancer patients
-
1:49
howard hochster, md, on the impact of swog 1406 in treating braf mutation positive crc patients
-
1:16
howard hochster md, provides thoughts on potential practice changing results of the keynote177 study
-
2:09
howard hochster, md, explains the role of ramucirumab in the treatment of ge junction cancers
-
4:53
a walk through dementia - at the supermarket
-
37:08
the hypothalamic-pituitary-adrenal axis part 5
-
15:11
overview of hlh - dr. michael jordan, md
-
2:09
howard hochster, md talks progress in the development of effective non msi-high immunotherapies
-
0:49
dr. kaseb on safety profile of atezolizumab plus bevacizumab in hcc
-
0:56
howard hochster, md, elaborates on how tumor sidedness affects therapeutic choice in mcrc patients
-
1:11
howard hochster, md on the economic benefit seen in calgb/swog 80405
-
1:53
howard hochster, md talks about predictive response therapy based on site of tumor in mcrc
-
5:35
howard hochster, md, discusses the outcomes of the keynote-177 study in metastatic crc
-
1:15
howard hochster, md, regarding the role of genetic testing in mcrc
-
2:16
howard hochster, md explains outcomes from the phase 3 calgb/swog 80405 study
-
1:19
howard hochster, md, considers patient age and the oncotypedx recurrence score in crc
-
0:41
howard hochster, md, regarding the outcomes of the prodigy7 study in mcrc
-
1:17
howard hochster, md, tells us about the outcomes of ecog-7208 in 2nd line mcrc
Clip.africa.com - Privacy-policy